Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Beauty Health (SKIN) EBITDA Margin (2021 - 2025)

Beauty Health (SKIN) has disclosed EBITDA Margin for 5 consecutive years, with 9.42% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin rose 683.0% to 9.42% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.33% through Dec 2025, up 855.0% year-over-year, with the annual reading at 1.33% for FY2025, 855.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 9.42% at Beauty Health, up from 15.02% in the prior quarter.
  • The five-year high for EBITDA Margin was 41.52% in Q1 2022, with the low at 317.96% in Q3 2021.
  • Average EBITDA Margin over 5 years is 34.53%, with a median of 9.42% recorded in 2025.
  • The sharpest move saw EBITDA Margin soared 31603bps in 2022, then tumbled -7497bps in 2023.
  • Over 5 years, EBITDA Margin stood at 26.51% in 2021, then soared by 134bps to 8.89% in 2022, then tumbled by -185bps to 7.58% in 2023, then tumbled by -114bps to 16.25% in 2024, then surged by 42bps to 9.42% in 2025.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 9.42%, 15.02%, and 29.85% for Q4 2025, Q3 2025, and Q2 2025 respectively.